Identification of temperature-insensitive residues in regulating SARS-CoV-2 variants-human ACE2 interaction-a study of molecular dynamics simulation.

Identification of temperature-insensitive residues in regulating SARS-CoV-2 variants-human ACE2 interaction-a study of molecular dynamics simulation.

Publication date: Sep 09, 2025

The COVID-19 pandemic remains a global health crisis, with successive SARS-CoV-2 variants exhibiting enhanced transmissibility and immune evasion. Notably, the Omicron variant harbors extensive mutations in the spike protein’s receptor-binding domain (RBD), altering viral fitness. While temperature is a critical environmental factor modulating viral stability and transmission, its molecular-level effects on variant-specific RBD-human angiotensin-converting enzyme 2 (hACE2) interactions remain underexplored. Here, we employed all-atom molecular dynamics (MD) simulations to investigate temperature-dependent conformational dynamics of four major variants (alpha, beta, delta, and omicron) complexed with hACE2 at three temperatures (190 K, 250 K, and 310 K). Our analyses revealed two temperature-insensitive residues (K417N and E484K/A) in beta and omicron variants that maintain stable conformational states between 250 K and 310 K, contrasting sharply with temperature-dependent fluctuations observed in alpha and delta variants. These residues function as an allosteric converter, modulating interfacial interactions through temperature-regulated electrostatic and hydrophobic forces. Furthermore, we identified key “effector” residues (Q493, Y501 in beta; F486, R498 in omicron) that mediate temperature-dependent binding affinity changes. Our findings provide mechanistic insights into variant-specific environmental adaptation and propose novel targets for broad-spectrum therapeutic design.

Concepts Keywords
Environmental Beta
Fitness Binding
Molecular Cov
Pandemic Dependent
Viral Dynamics
Human
Insensitive
Molecular
Omicron
Rbd
Residues
Sars
Temperature
Variant
Variants

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease IDO protein

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *